Assessing the Use of Solid-Phase Cytometry for Rapid Bioburden Testing

Abstract The development of new and more complex modalities brings exciting opportunities to drug development, however, there are also challenges. With increased complexity often comes increased manufacturing times, cost and sometimes short shelf life. It is important the pharmaceutical microbiology...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter and WEBINAR UPDATES

We will not sell or give your information to a third party. See our Privacy Policy